sr 95531 has been researched along with cytarabine in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
---|---|---|---|---|---|
610 | 0 | 209 | 15,487 | 2,424 | 3,188 |
Protein | Taxonomy | sr 95531 (IC50) | cytarabine (IC50) |
---|---|---|---|
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herzig, KH; Hoepfner, M; Jansen, A; Riecken, EO; ScherĂ¼bl, H | 1 |
1 other study(ies) available for sr 95531 and cytarabine
Article | Year |
---|---|
GABA(C) receptors in neuroendocrine gut cells: a new GABA-binding site in the gut.
Topics: Acrylates; Animals; Bicuculline; Calcium; Cholecystokinin; Cytarabine; GABA Antagonists; gamma-Aminobutyric Acid; Gene Expression; Immunohistochemistry; Intestinal Neoplasms; Kinetics; Mice; Mice, Transgenic; Neuroendocrine Tumors; Organophosphorus Compounds; Pyridazines; Receptors, GABA; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2000 |